The novel biomarker, neopterin, can predict the severity of COVID-19.
Sign Up to like & getrecommendations! Published in 2022 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202208_29428
Abstract: OBJECTIVE SARS-CoV-2 infection primarily affects T-lymphocytes, particularly CD4+ and CD8+ T cells. However, there is a need for simpler and less expensive laboratory tests with predictive values comparable to CD4+ cell counts. Thus, the goal… read more here.
Keywords: intensive care; covid patients; covid; biomarker neopterin ... See more keywords